Skip to Content

Summary Slides & Reports

Main Content

CIBMTR data on outcomes and trends are summarized and made available for clinical decision-making, presentations, and research planning.

The US Summary Slides - HCT Trends and Survival Data

Using information from our outcomes database, CIBMTR annually prepares and distributes charts summarizing current uses and outcomes of allogeneic and autologous hematopoietic cell transplantation (HCT) in a set of US Summary Slides.

The US Summary Slides

The US Summary Slides are an annual report on data submitted to CIBMTR by centers in the US and describes information related to practices and general survival outcomes after hematopoietic cell transplantation. The current edition includes transplants performed prior to 2021.

  • The US Summary Slides 2022 (PowerPoint) - Updated August 2023
    • To cite the US Summary Slides
      • Citation: Bolon YT, Atshan R, Allbee-Johnson M, Estrada-Merly N, Lee SJ. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR summary slides, 2022. 
    • Slides 3 to 77 exhibit data on frequency of transplants according to transplant type, donor, patient age, graft source, GVHD prophylaxis, disease, causes of death, conditioning regimen, and race and/or ethnicity. All frequencies represent first autologous and allogeneic transplants registered with CIBMTR during the period. 

    • Slides 78 to 95 include overall survival outcomes according to age, donor type, disease, disease status, year of transplant, and race and ethnicity. Comparisons across survival curves are univariate and do not adjust for all potentially important factors; consequently, results should be interpreted cautiously.

  • Race and Ethnicity section in the 2021 Summary Slides
    • Citation: Auletta JJ, Kou J, Chen M, Shaw BE. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides, 2021.
  • Slides are also available upon request by contacting

Cellular Therapy Summary Slides

Summary of the current use, outcomes, trends of cellular therapies in the United States


US Transplant and Survival Statistics on Related Sites

In addition to the data and resources available through this website, hematopoietic cell transplantation (HCT) data collected and analyzed by CIBMTR are also available through related websites.

In this section:
C.W. Bill Young Cell Transplantation Program website
NMDP website

C.W. Bill Young Cell Transplantation Program website

Autologous, Related and Unrelated Allogeneic Transplant Data

In 2006, CIBMTR was awarded a contract from the Health Resources and Services Administration of the US Department of Health and Human Services to administer the Stem Cell Therapeutic Outcomes Database (SCTOD) of the C.W. Bill Young Cell Transplantation Program.

As a part of this contract, CIBMTR provides statistics about autologous, related, and unrelated allogeneic transplants performed by US transplant centers:

  • US Patient Survival Report
    View patient survival estimates for a disease and the length of time after transplant: 100 days, 1 year, and 3 years. You can also select survival estimates by patient age, patient gender, patient race, or cell source.
  • US Transplant Data by Center Report
    View the number of bone marrow and cord blood transplants performed at a specific transplant center.
  • US Transplant Data by Disease Report
    View the number of bone marrow and cord blood transplants reported for a specific disease. You can also select patient age, patient gender, patient race, and cell source and view the year when the transplant was performed.
  • HRSA Transplant Activity Report
    View tables reflecting the number of bone marrow and cord blood transplants performed at transplant centers in the US, by patient age, patient gender, patient race, cell source, the year when the transplant was performed, disease, donor type, and the state in which the transplant center is located.

NMDP website

Allogeneic Transplant Data, by Transplant Center

CIBMTR performs a center-specific survival analysis each year as part of the C.W. Bill Young Cell Transplantation Program. The methodology for this analysis (click to view the previous methodology) is reviewed at the Center Outcomes Forum every other year. The results of this analysis are incorporated into a comprehensive guide of all US transplant centers that perform allogeneic transplants (using related or unrelated donors). The listing includes the kinds of transplants performed, transplant outcomes, diseases treated, and general cost information for each center.

  • US Transplant Center Listing
    Each transplant center listing includes information about facilities, personnel, diseases treated, cost, and transplant experience, including the number of transplants performed and survival rates by age, disease type, and disease stage.


Publication Permission Request

Use the form below to request permission to reproduce CIBMTR slides or data. Your request will receive prompt attention.

Publication Permission Request Form

Please note that a permission request is subject to the following conditions:

  • If used publicly, the following statement must be included: “The views expressed in this article are that of the authors and does not reflect the position of the Center for International Blood and Marrow Transplant Research.”

  • Appropriate credit for CIBMTR data is required.

  • Except as herein provided, no adaptation of changes shall be made to CIBMTR's materials without prior written consent of CIBMTR.

  • CIBMTR material shall be used only in the manner as described above. If CIBMTR material is sought for inclusion in a new edition or updated version to a document or publication from which copyright permission is currently being sought, a new CIBMTR Copyright Permission Request Form must be submitted to CIBMTR.